Farfield Scientific entered into a strategic partnership with Monash University to create biosensor surfaces for the structural analysis of membrane protein function. SEQUENOM named Richard Lerner to its Board in July. He is president of the Scripps Research Institute. A consortium that includes deltaDOT, Xcellerex, BioPharm Services and Dowpharma was awarded a $7.9 million DARPA grant to develop technology to accelerate the production of vaccines and protein therapeutics. deltaDOT appointed Dr. Peter Coggins, former president of PerkinElmer Life and Analytical Sciences, and Ed Robinson, former executive vice president of Europe and Asia Pacific Pharma and Biopharmaceuticals for Cambrex, to its Board. LI-COR Biosciences appointed M&S TechnoSystems as the Japanese distributor for LI-COR Biotechnology Products effective September 1, replacing Aloka. In August, SEQUENOM raised its 2007 guidance for sales from $37–$39 million to $39–$41 million and lowered its 2007 net loss guidance from $23–$25 million to $19–$21 million. Lumera CEO Tom Mino resigned in August. A search for a new CEO is underway. Lumera’s Plexera Bioscience subsidiary named Ulf Jonsson, PhD, former CEO of Biacore, and Auguron Biosciences President and CEO Jim Richey to its Board. ForteBio named Bucher Biotec AG as its exclusive Swiss distributor and Millennium Science as its distributor for Australia and New Zealand. NextGen CEO Dr. James G. Heffernan left the company in August. Applied Biosystems launched a Software Development Initiative for its SOLiD sequencing platfom, including open access to the platform’s sample data sets, data file formats and data conversion tools. ART Advanced Research Technologies named Dino DiCamillo as vice president, Global Sales & Marketing, Preclinical Imaging. He was previously president of the proteomic technology division of AlfaWassermann.